One-year adherence to warfarin treatment for venous thromboembolism in high-risk patientsand its association with long-term risk of recurrent events

Journal of Managed Care Pharmacy

Volumn 19, Issue 4, 2013, Pages 291-301

  Chen, Shih Yin ^a   Wu, Ning ^a   Gulseth, Michael ^b   LaMori, Joyce ^c   Bookhart, Brahim K ^c   Boulanger, Luke ^a   Fields, Larry ^c   Schein, Jeff ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CHARLSON COMORBIDITY INDEX; DEMOGRAPHY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; RECURRENT DISEASE; SENSITIVITY ANALYSIS; SEX RATIO; SURVIVAL RATE; VENOUS THROMBOEMBOLISM;

EID: 84878952901     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2013.19.4.291     Document Type: Article

References (18)

1. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4 Suppl): S495-S501.
2. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4-I8.
3. Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med. 2008;168(4):425-30.
4. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117(1):19-25.
5. Hansson PO, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med. 2000;160(6):769-74.
6. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160(6):761-68.
7. Summaries for patients. Treatment of venous thromboembolism: recommendations from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2007;146(3):I43.
8. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th ed.). Chest. 2008;133(6 Suppl):454S- 545S.
9. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest. 2008;133(6 Suppl):160S-198S.
10. Ganz DA, Glynn RJ, Mogun H, Knight EL, Bohn RL, Avorn J. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med. 2000;15(11):776-81.
11. Deitelzweig SB, Lin J, Kreilick C, Hussein M, Battleman D. Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes. Adv Ther. 2010;27(9):623-33.
12. Willey VJ, Bullano MF, Hauch O, et al. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting. Clin Ther. 2004;26:1149-59.
13. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565-74; discussion: 575-67.
14. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-51.
15. Witt DM, Delate T, Clark NP, et al. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood. 2009;114(5):952-56.
16. Hylek EM, Chang YC, Skates SJ, et al. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med. 2000;160(11):1612-17.
17. Caprini JA, Tapson VF, Hyers TM, et al. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg. 2005;42(4):726-33.
18. Platt AB, Localio AR, Brensinger CM, et al. Can we predict daily adherence to warfarin? Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Chest. 2010;137(4):883-89.